| Announce Date | 12/11/2025 |
| EPS Normalized Actual | $-0.3 (Miss by $-0.19) |
| EPS GAAP Actual | $-0.3 (Miss by $-0.19) |
| Revenue Actual | $0.062253B |
| Revenue Surprise | Beat by $62.253M |
| Announce Date | 02/01/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.005 |
| EPS GAAP Estimate | $-0.005 |
| Revenue Estimate | $0.0804675B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2027 | 0.55 | 4.6 | 0.53712 | 0.56288 | 1 |
| Jan 2027 | 0.05 | 50.6 | 0.05 | 0.05 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -0.44 | -0.66 | 0.062253B | -29.44% | -69.06M |
| FQ3 2025 (Aug 2025) | -0.17 | -0.17 | 0.070858B | -56.4% | 70.86M |
| FQ2 2025 (May 2025) | -1.2 | -1.2 | 0.051652B | -56.05% | 51.65M |
| FQ1 2025 (Feb 2025) | -1.69 | -1.69 | 0.099964B | -33.31% | 99.96M |
| FQ4 2024 (Nov 2024) | -0.46 | -0.46 | 0.080578B | -42.7% | 80.58M |
| FQ3 2024 (Aug 2024) | 0.19 | 0.19 | 0.110822B | -15.66% | 110.82M |
| FQ2 2024 (May 2024) | -0.26 | -0.26 | 0.080603B | -17.07% | 80.6M |
| FQ1 2024 (Feb 2024) | -0.0602 | -0.0602 | 0.133265B | -10.37% | 133.27M |
FQ4 Announce Date
02/01/2026 (Pre-Market)
Consensus EPS Estimates
-0.005
Consensus Revenue Estimates
0.0804675B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 0.11 | -- | 0.10883 | 0.11117 | 1 |
| FQ4 2026 (Nov 2026) | 0.14 | 414.29 | 0.13851 | 0.14149 | 1 |
| FQ3 2026 (Aug 2026) | 0.2 | 185 | 0.19787 | 0.20213 | 1 |
| FQ2 2026 (May 2026) | -0.1 | -1100 | -0.10106 | -0.09893552 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 0.13B | -- | 0.13B | 0.13B | 1 |
| FQ4 2026 (Nov 2026) | 0.09B | 33.19 | 0.09B | 0.09B | 1 |
| FQ3 2026 (Aug 2026) | 0.12B | 43.09 | 0.12B | 0.13B | 1 |
| FQ2 2026 (May 2026) | 0.09B | 40.81 | 0.09B | 0.09B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.22 | -0.44 | -0.66 | 150% |
| FQ3 2025 (Aug 2025) | -0.17 | -0.17 | 100% | |
| FQ2 2025 (May 2025) | -1.2 | -1.2 | 100% | |
| FQ1 2025 (Feb 2025) | -1.69 | -1.69 | 100% | |
| FQ4 2024 (Nov 2024) | -0.46 | -0.46 | 100% | |
| FQ3 2024 (Aug 2024) | 0.19 | 0.19 | 100% | |
| FQ2 2024 (May 2024) | -0.26 | -0.26 | 100% | |
| FQ1 2024 (Feb 2024) | -0.0602 | -0.0602 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0.13B | $0.06B | $-69.06M | -110.94% |
| FQ3 2025 (Aug 2025) | $0B | $0.07B | $70.86M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.05B | $51.65M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.1B | $99.96M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.08B | $80.58M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $0.11B | $110.82M | 100% |
| FQ2 2024 (May 2024) | $0B | $0.08B | $80.6M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $0.13B | $133.27M | 100% |